A detailed history of Texas Yale Capital Corp. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Texas Yale Capital Corp. holds 10,000 shares of GOSS stock, worth $11,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$11,800
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$0.66 - $1.07 $6,600 - $10,700
10,000 New
10,000 $9,000
Q4 2022

Feb 13, 2023

BUY
$1.74 - $12.87 $17,400 - $128,699
10,000 New
10,000 $21,000
Q1 2022

May 10, 2022

SELL
$8.44 - $12.49 $84,400 - $124,900
-10,000 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$8.0 - $9.75 $80,000 - $97,500
10,000 New
10,000 $81,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $111M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Texas Yale Capital Corp. Portfolio

Follow Texas Yale Capital Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.